Skip to content

Effectiveness of Bronchodilator Nebulization With and Without Noninvasive Ventilation in COPD

Effectiveness of Bronchodilator Nebulization With and Without Noninvasive Ventilation During Respiratory Failure in Chronic Obstructive Pulmonary Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03481543
Enrollment
11
Registered
2018-03-29
Start date
2018-04-10
Completion date
2020-11-12
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD), Type 2 Respiratory Failure

Keywords

Chronic Obstructive Pulmonary Disease (COPD), Nebulization, Respiratory failure, Non-invasive ventilation(NIV)

Brief summary

The study aim to evaluate effectiveness of two bronchodilator nebulization strategies in patients with acute decompensated type 2 respiratory failure due to acute exacerbation of chronic obstructive pulmonary disease..

Detailed description

Decompensated type 2 respiratory failure during acute exacerbation of chronic obstructive pulmonary disease (COPD) is treated with non-invasive ventilation (NIV) and nebulized bronchodilators. Nebulization during NIV can be applied by two methods: in-line nebulization through NIV mask and off-NIV nebulization during which NIV mask is taken off for a short time and reapplied when nebulization is finished. This study is a prospective randomized controlled trial to compare in-line nebulization through NIV versus off- NIV nebulization. After starting NIV in eligible COPD patients with type 2 respiratory failure, the baseline end-expiratory lung impedance (EELI) will be measured. Patient is randomized to receive either in-line or off-NIV nebulization. EELI will be measured again following completion of the nebulization, 15min after NIV is restarted (off-NIV group) or continued (in-line group). Ultrasound measurement of the thickness of the diaphragm will be recorded at baseline, 15min after NIV is restarted (off-NIV group) or continued (in-line group) and 48 hours after stopping the NIV. The main outcome measure, difference in mean end expiratory lung volume at 15min after NIV is restarted (off-NIV group) or continued (in-line group) between the two nebulization methods will be compared using independent sample T test. Thickness of the diaphragm and changes in the arterial blood gases (in terms of pH and carbon-di-oxide) will be compared between in-line nebulization and off-NIV nebulization.

Interventions

PROCEDUREIn-line nebulization through NIV mask

In-line nebulization will be given through NIV circuit.

PROCEDUREOff-NIV nebulization

Bronchodilator nebulization is given during which NIV mask is taken off for a short time and reapplied when nebulization is finished..

Sponsors

National University Health System, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥21 years. 2. Known or suspected COPD (defined by a ratio of Forced Expiratory Volume in 1 second (FEV1) to Forced Vital Capacity (FVC) of less than 0.7). 3. Acute decompensated type 2 respiratory failure (ABG pH ≤ 7.35 and PaCO2\>45mmHg). 4. Clinical decision made to start NIV.

Exclusion criteria

1. Other acute decompensated type 2 respiratory failure related conditions (e.g. neuromuscular, heart failure etc.). 2. Pneumonia present in the chest radiograph. 3. Other conditions which may change lung impedance (e.g. heart failure or lung fibrosis).

Design outcomes

Primary

MeasureTime frameDescription
Difference in mean end-expiratory lung volumes between the two nebulization methods.At baseline (approximately 15min after starting NIV) to approximately 15min after restarting (or continuing NIV) following the nebulization.End-expiratory lung volumes between in-line nebulization and off-NIV nebulization.

Secondary

MeasureTime frameDescription
Thickness of the diaphragm (by ultrasound) between in-line nebulization and off-NIV nebulization.At baseline (approximately 15min after starting NIV) to approximately 15min after restarting (or continuing NIV) following the nebulization and repeated 48hours after stopping NIV.Measure thickness of the diaphragm between inspiration and expiration.
Changes in arterial blood gases in terms of pH and carbon dioxide between in-line. nebulization and off-NIV nebulization.At baseline (approximately 15min after starting NIV) to approximately 15min after restarting (or continuing NIV) following the nebulization.Measure changes of arterial blood gases between in-line nebulization and off-NIV. nebulization. Differences in pH (absolute,no unit) and carbon dioxide (in mmHg) will be noted.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026